Intercenter Agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 4, 2007, Pages 881-885

  Jasperse, Bas ^a   Valsasina, Paola ^b   Neacsu, Veronica ^a   Knol, Dirk L ^a   De Stefano, Nicola ^c   Enzinger, Christian ^d   Smith, Stephen M ^e   Ropele, Stefan ^d   Korteweg, Tijmen ^a   Giorgio, Antonio ^c   Anderson, Valerie ^f   Polman, Chris H ^a   Filippi, Massimo ^b   Miller, David H ^f   Rovaris, Marco ^b   Barkhof, Frederik ^a   Vrenken, Hugo ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Agreement; Brain volume; MRI; Multicenter; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; AUTOMATION; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ATROPHY; AUTOMATION; BRAIN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MODELS, STATISTICAL; MULTIPLE SCLEROSIS; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS;

EID: 35148889225     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21101     Document Type: Article

References (13)

1. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125(Pt 8): 1676-1695.
2. Filippi M, Paty DW, Kappos L, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995;45:255-260.
3. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol 1996;39:6-16.
4. Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002;59:1412-1420.
5. Smith SM, Zhang YY, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-489.
6. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(S1):208-219.
7. Sormani MP, Rovaris M, Valsasina P, Wollnsky JS, Comi G, Fillppi M. Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis. Neurology 2004;62:1432-1434.
8. Jasperse B, Minneboo A, de Groot, V, et al. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. Arch Neurol 2007;64:190-194.
9. Coml G, Fillppi M, Wolinsky JS. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging - measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. Ann Neurol 2001;49:290-297.
10. Comi G, Filippi M, Barkhof F, et al. Effect of early Interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001;357:1576-1582.
11. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143-155.
12. Carrasco JL, Jover L. Estimating the generalized concordance correlation coefficient through variance components. Biometrics 2003;59:849-858.
13. Mood AM, Grayblll FA, Boes DC. Tests of hypotheses. In: Introduction to the theory of statistics, 3rd edition. New York: McGraw-Hill; 1974. p 438.